M&A Deal Summary

Aspen Pharmacare Acquires Sigma Pharmaceuticals - Pharmaceutical Business

On August 16, 2010, Aspen Pharmacare acquired life science company Sigma Pharmaceuticals - Pharmaceutical Business from Sigma Healthcare for 900M AUD

Acquisition Highlights
  • This is Aspen Pharmacare’s 1st transaction in the Life Science sector.
  • This is Aspen Pharmacare’s largest (disclosed) transaction.
  • This is Aspen Pharmacare’s 1st transaction in Australia.

M&A Deal Summary

Date 2010-08-16
Target Sigma Pharmaceuticals - Pharmaceutical Business
Sector Life Science
Buyer(s) Aspen Pharmacare
Sellers(s) Sigma Healthcare
Deal Type Divestiture
Deal Value 900M AUD

Target

Sigma Pharmaceuticals - Pharmaceutical Business

Australia
Sigma Pharmaceuticals Ltd - Pharmaceutical Business consists of an extensive product portfolio of branded, generic and OTC products which include many well-known and trusted Australian brands as well as five manufacturing facilities. Sigma retains its wholesale business, and is one of three major wholesaler distributors in Australia.

Search 191,421 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Aspen Pharmacare

Durban, South Africa

website


Category Company
Founded 1850
Sector Life Science
Employees8,580
Revenue 38.6B ZAR (2022)
DESCRIPTION

Aspen Pharmacare is a global player in specialty, branded and generic pharmaceuticals, Aspen has an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. The Group continues to increase the number of lives benefitting from its products, reaching more than 150 countries. In line with the Group’s commercial, production and territorial strategies, Aspen has identified thrombosis, anaesthetics, high potency & cytotoxics and infant nutritionals as four therapeutic categories which will get the highest focus based on materiality and future potential. Aspen Pharmacare was founded in 1850 and is based in Durban, South Africa.


DEAL STATS #
Overall 1 of 4
Sector (Life Science) 1 of 3
Type (Divestiture) 1 of 3
Country (Australia) 1 of 2
Year (2010) 1 of 1
Size (of disclosed) 1 of 3
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-15 GlaxoSmithKline - 25 Pharmaceutical Products

Australia

GlaxoSmithKline - 25 Pharmaceutical Products comprise long established pharmaceutical brands of proven performance. The main areas of therapeutic treatment of the Products are analgesic, antibiotics, anti-virals and the central nervous system. Other areas covered include anti-nauseant, anti-inflammatory and muscle relaxants. The leading Products are well recognised brands including Amoxil, Augmentin, Imigran, Kapanol, Lamactil, Mesasal, Timentin, Valtrex, Zantac and Zofran.

Buy £172M

Seller(S) 1

SELLER

Sigma Healthcare

Rowville, Australia

website


Category Company
Founded 1912
Sector Medical Products
Revenue 3.5B AUD (2022)
DESCRIPTION

Sigma Healthcare is a Australian full line wholesale and distribution business to pharmacy. Sigma has the major pharmacy-led network in Australia, with over 1200 branded and independent pharmacies in network, including some of Australia’s best known pharmacy retail brands in Amcal, Amcal Max, Guardian, Pharmasave, Chemist King and Discount Drug Stores. Sigma Healthcare was founded in 1912 and is based in Rowville, Australia.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Australia) 1 of 1
Year (2010) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-01 Orphan Holdings Pty

South Croydon, Australia

Buy AU$130M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-05-26 Central Healthcare Group

Australia

Central Healthcare Group is a wholesaler and distributor of pharmaceutical products to hospitals and retail pharmacies and is an approved CSO distributor in Victoria, New South Wales, ACT and Queensland. Central Healthcare also owns and manages the PharmaSave brand.

Buy AU$41M